XML 71 R6.htm IDEA: XBRL DOCUMENT v3.19.3
Unaudited Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 28, 2019
Sep. 29, 2018
Cash flow from operating activities:    
Net income $ 24,726 $ 54,957
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, depletion, amortization and accretion 166,997 152,829
Share-based compensation expense 15,424 19,833
Net gain on asset disposals (8,030) (27,261)
Non-cash loss on debt financings 2,850 0
Change in deferred tax asset, net 32,736 12,577
Other (1,609) 873
(Increase) decrease in operating assets, net of acquisitions and dispositions:    
Accounts receivable, net (121,196) (90,481)
Inventories 16,296 (26,027)
Costs and estimated earnings in excess of billings (31,085) (37,643)
Other current assets 5,635 (6,819)
Other assets 4,992 (1,217)
(Decrease) increase in operating liabilities, net of acquisitions and dispositions:    
Accounts payable 52,423 24,978
Accrued expenses 8,447 (2,197)
Billings in excess of costs and estimated earnings (618) 3,850
Tax receivable agreement liability 424 1,812
Other liabilities (5,805) (1,807)
Net cash provided by operating activities 163,843 70,557
Cash flow from investing activities:    
Acquisitions, net of cash acquired (2,842) (210,894)
Purchases of property, plant and equipment (139,762) (183,752)
Proceeds from the sale of property, plant and equipment 13,035 18,426
Proceeds from sale of business 0 21,564
Other (207) 2,660
Net cash used for investing activities (129,776) (351,996)
Cash flow from financing activities:    
Proceeds from debt issuances 300,000 64,500
Debt issuance costs (6,312) (550)
Payments on debt (264,906) (79,027)
Payments on acquisition-related liabilities (11,000) (35,321)
Distributions from partnership 0 (69)
Proceeds from stock option exercises 2,559 15,615
Other (501) (1,913)
Net cash provided by (used in) financing activities 19,840 (36,765)
Impact of foreign currency on cash 174 (422)
Net increase (decrease) in cash 54,081 (318,626)
Cash and cash equivalents—beginning of period 128,508 383,556
Cash and cash equivalents—end of period 182,589 64,930
Summit Materials, LLC    
Cash flow from operating activities:    
Net income 47,136 68,433
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, depletion, amortization and accretion 166,594 152,279
Share-based compensation expense 15,424 19,833
Net gain on asset disposals (8,030) (27,261)
Non-cash loss on debt financings 2,850 0
Change in deferred tax asset, net 11,153 1,463
Other (1,609) 873
(Increase) decrease in operating assets, net of acquisitions and dispositions:    
Accounts receivable, net (121,196) (90,481)
Inventories 16,296 (26,027)
Costs and estimated earnings in excess of billings (31,085) (37,643)
Other current assets 5,635 (6,819)
Other assets 4,992 (1,217)
(Decrease) increase in operating liabilities, net of acquisitions and dispositions:    
Accounts payable 51,728 24,392
Accrued expenses 9,142 (1,611)
Billings in excess of costs and estimated earnings (618) 3,850
Other liabilities (5,805) (1,807)
Net cash provided by operating activities 163,843 70,557
Cash flow from investing activities:    
Acquisitions, net of cash acquired (2,842) (210,894)
Purchases of property, plant and equipment (139,762) (183,752)
Proceeds from the sale of property, plant and equipment 13,035 18,426
Proceeds from sale of business 0 21,564
Other (207) 2,660
Net cash used for investing activities (129,776) (351,996)
Cash flow from financing activities:    
Capital contributions by member 2,559 15,615
Proceeds from debt issuances 300,000 64,500
Debt issuance costs (6,312) (550)
Payments on debt (264,906) (79,027)
Payments on acquisition-related liabilities (8,500) (32,821)
Distributions from partnership (2,500) (2,569)
Other (501) (1,913)
Net cash provided by (used in) financing activities 19,840 (36,765)
Impact of foreign currency on cash 174 (422)
Net increase (decrease) in cash 54,081 (318,626)
Cash and cash equivalents—beginning of period 128,508 383,556
Cash and cash equivalents—end of period $ 182,589 $ 64,930